TrianglePUBLICATIONS · 34270348
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2021 Nov 1
- First author
- DuBois SG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- DuBois SG
- type
- Author
- name
- Granger MM
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Tsao-Wei D
- type
- Author
- name
- Ji L
- type
- Author
- name
- Shamirian A
- type
- Author
- name
- Czarnecki S
- type
- Author
- name
- Goodarzian F
- type
- Author
- name
- Berkovich R
- type
- Author
- name
- Shimada H
- type
- Author
- name
- Villablanca JG
- type
- Author
- name
- Vo KT
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- DuBois SG
- type
- Author
- name
- Granger MM
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Tsao-Wei D
- type
- Author
- name
- Ji L
- type
- Author
- name
- Shamirian A
- type
- Author
- name
- Czarnecki S
- type
- Author
- name
- Goodarzian F
- type
- Author
- name
- Berkovich R
- type
- Author
- name
- Shimada H
- type
- Author
- name
- Villablanca JG
- type
- Author
- name
- Vo KT
- type
- Author
- bibliography ids
- nci-bib-46c7876766c52c02015ead16
- book metadata
- content sha256
- 3fb3918f6fbfd79f4ca20fdf7f41172cca4d54e7da71249e83a122874862db6d
- document type
- citation
- dois
- 10.1200/JCO.21.00703
- electronic publication date
- display
- 2021 Jul 16
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34270348
- immutable id
- pubmed:34270348@3fb3918f6fbfd79f4ca20fdf7f41172cca4d54e7da71249e83a122874862db6d
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 31
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3506-3514
- volume
- 39
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34270348
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- f1db61ec664ac40f1c094cdf80b8c49f5cdcad1a4c546c93de684fc5d1386839
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Nov 1
- precision
- day
- year
- 2021
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
Preserved source evidence · Not medical advice